4
Changes in Ownership
UroGen Pharma Ltd. Filed Acc 0001209191-20-034672
Chief Medical Officer sold 349 shares at $27.51 ($9,602)
- Chief Medical Officer acquired 1,042 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schoenberg Mark Chief Medical Officer | 2020-06-04 | Option exercise | +1,042 | 18,753 | D: show line 1 in the form | ||
| Schoenberg Mark Chief Medical Officer | 2020-06-04 | Sale | −349 | $27.51 | $9,602 | 18,404 | D: show line 2 in the form |
| Open-market sales · 349 sh · avg $27.51 · $9,602 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Schoenberg Mark Chief Medical Officer | 2020-06-04 | Option exercise · Restricted Stock Units | −1,042 | 1,042 | 2,083 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…